poisar

Stocks · News reference

Mizuho Maintains Outperform on LifeMD, Lowers Price Target to $6

BenzingaBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Fiscal.ai

    LifeMD, Inc. Delays Q3 2026 10-Q Filing

    LifeMD, Inc. has announced a delay in filing its Form 10-Q for the third quarter of 2026 to correct errors related to revenue and expense recognition.